The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death.
Pozzi C, Cuomo A, Spadoni I, Magni E, Silvola A, Conte A, Sigismund S, Ravenda PS, Bonaldi T, Zampino MG, Cancelliere C, Di Fiore PP, Bardelli A, Penna G, Rescigno M.
Pozzi C, et al. Among authors: ravenda ps.
Nat Med. 2016 Jun;22(6):624-31. doi: 10.1038/nm.4078. Epub 2016 May 2.
Nat Med. 2016.
PMID: 27135741